Gracevit Tab 50 is contraindicated in the following patients: Patients with a history of hypersensitivity to any ingredients of Gracevit Tab 50 or other quinolones.
Pregnant women or women suspected of being pregnant (See Use in Pregnancy & Lactation).
Pediatric patients (See Pharmacology: Toxicology: Preclinical Safety Data under Actions): The safety of Gracevit Tab 50 in low birth weight infants, newborn infants, infants and toddlers, children and adolescents has not been established.